Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans

Yi Xu1, Hui Lu2, Shuo Zhu2

  • 1Department of Pharmacy, The 960 Hospital of PLA, Jinan, China.

Microbiology Spectrum
|June 23, 2021
PubMed

Insights

Drug tolerance in Candida albicans is influenced by temperature, growth medium, and specific genes like CDR1. Vacuolar function is crucial for ketoconazole tolerance, highlighting complex regulatory mechanisms against fungal infections.

Area of Science:

  • Mycology
  • Antimicrobial Resistance

Background:

  • Candida albicans is a major opportunistic fungal pathogen with limited treatment options.
  • Antifungal drug tolerance and resistance reduce therapeutic efficacy, posing a global health threat, especially to immunocompromised individuals.

Purpose of the Study:

  • Investigate factors influencing ketoconazole tolerance and resistance in Candida albicans.
  • Differentiate mechanisms underlying drug tolerance versus resistance.

Main Methods:

  • Deletion analysis of efflux pump genes (CDR1, CDR2, MDR1).
  • Assessed the role of Hsp90, calcineurin pathway components (CRZ1), and vacuolar ATPase (VMA11).
  • Utilized concanamycin A to inhibit vacuolar ATPase activity.

Main Results:

  • Temperature and growth medium composition significantly impacted ketoconazole tolerance but not resistance.
  • CDR1 partially contributed to azole tolerance; CDR2 and MDR1 were dispensable.
  • Hsp90, calcineurin, and CRZ1 were involved in tolerance, with CRZ1 showing partial requirement.
  • Deletion of VMA11 or V-ATPase inhibition abolished tolerance, emphasizing vacuolar energy transaction importance.

Conclusions:

  • Ketoconazole tolerance in C. albicans is regulated by a combination of physiological and genetic factors.
  • Distinct and shared mechanisms govern drug tolerance and resistance, underscoring the complexity of antifungal drug response.

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
61
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
343
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
165
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
292